$3.05 -0.05 (-1.61%) PharmAthene Inc - NYSE Amex Equities

Dec. 2, 2016 | 04:00 PM

Quotes

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Last Trade: 3.05
Trade Time: Dec 02 04:00 PM Eastern Daylight Time
Change: -0.05 (-1.61%)
Prev Close: 3.10
Open: 3.10
Bid: 3.05
Ask: 3.10
  1. No results found.
  1. PharmAthene Reports SIGA Filed Reorganization Plan to Exit from Bankruptcy

    Benzinga | Dec. 15, 2015 | 18:59PM EST
  2. PharmAthene Announces U.S. Bankruptcy Court Partially Lifts Litigation Stay To Permit Delaware Court To Proceed Towards Final Judgment

    Benzinga | Oct. 8, 2014 | 11:30AM EST
  3. Midday Losers From September 16 - VirnetX Holding Corporation, Majesco Entertainment Co. And More

    Benzinga | Sep. 16, 2014 | 12:48PM EST
  4. New Non-Clinical Data Demonstrate SparVax Provides Equivalent Protection In Head-To-Head Comparison With BioThrax

    Benzinga | Sep. 9, 2014 | 08:03AM EST
  5. Stocks Hitting 52-Week Lows

    Benzinga | Aug. 11, 2014 | 09:21AM EST
  6. Morning Market Losers

    Benzinga | Aug. 11, 2014 | 08:52AM EST
  7. Morning Market Movers

    Benzinga | Aug. 11, 2014 | 08:45AM EST
  8. Why PharmAthene Is Up 56% In #PreMarket Trading

    Benzinga | Aug. 11, 2014 | 08:23AM EST
  9. PharmAthene Updates Status Of SparVax Anthrax Vaccine Contract

    Benzinga | Apr. 7, 2014 | 08:05AM EST
  10. UPDATE: H.C. Wainwright Initiates Coverage on PharmAthene

    Benzinga | Mar. 10, 2014 | 15:12PM EST
  11. Prescott Group Urges PharmAthene Shareholders to Vote Against Proposed Theraclone Merger

    Benzinga | Nov. 29, 2013 | 07:04AM EST
  12. Prescott Group Urges PharmAthene Shareholders to Vote Down Proposed Theraclone Merger

    Benzinga | Nov. 27, 2013 | 07:03AM EST
  13. PharmAthene Reports New Non-Clinical Data Demonstrating SparVax Anthrax Vaccine Can Provide Protection Against Lethal Anthrax Challenge

    Benzinga | Sep. 13, 2013 | 07:37AM EST
  14. Benzinga's Small Cap Movers for Friday January 11, 2013

    Benzinga | Jan. 13, 2013 | 04:10AM EST
  15. PharmAthene Announces Further Progress In Development Of Its SparVax Anthrax Vaccine Program

    Benzinga | Jun. 14, 2012 | 04:15AM EST
Trading Center